Pemberdayaan Anak Dalam Pencegahan Anemia Di PMB Fina Sembiring Medan Tahun 2023
Sevaka : Hasil Kegiatan Layanan Masyarakat · 2024
DOI: 10.62027/sevaka.v2i1.47 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sevaka : Hasil Kegiatan Layanan Masyarakat, 2024. Verfasst von Nurmalina Hutahaean und 5 weiteren Autor:innen.
Abstract (Originalsprache)
This community engagement initiative aims to empower children in the prevention of anemia in PMB Fina Sembiring, Medan, in 2023. The approach involves collaboration between educational institutions, the community, and relevant stakeholders to design a child empowerment program. Concrete steps include nutritional education, the formation of children's education groups, and the development of tailored educational materials. Impact assessment is conducted to evaluate the program's effectiveness in enhancing children's knowledge of balanced nutrition, promoting dietary changes, and reducing the prevalence of anemia. The anticipated outcomes aim to contribute positively to children's health and provide a foundation for similar program planning in surrounding communities.
Zitieren
APA
Hutahaean, N., Napitupulu, N. I. M. B., Simanjuntak, M., Kabeakan, E., Munthe, F. Y., & Safitri, E. (2024). Pemberdayaan Anak Dalam Pencegahan Anemia Di PMB Fina Sembiring Medan Tahun 2023. Sevaka : Hasil Kegiatan Layanan Masyarakat. https://doi.org/10.62027/sevaka.v2i1.47
Vancouver
Hutahaean N, Napitupulu NIMB, Simanjuntak M, Kabeakan E, Munthe FY, Safitri E. Pemberdayaan Anak Dalam Pencegahan Anemia Di PMB Fina Sembiring Medan Tahun 2023. Sevaka : Hasil Kegiatan Layanan Masyarakat. 2024. doi:10.62027/sevaka.v2i1.47
BibTeX
@article{Hutahaean2024,
author = {Hutahaean, Nurmalina and Napitupulu, Nova Isabella Mariance Br and Simanjuntak, Merrygrace and Kabeakan, Enjelika and Munthe, Feprika Yanti and Safitri, Evi},
title = {Pemberdayaan Anak Dalam Pencegahan Anemia Di PMB Fina Sembiring Medan Tahun 2023},
journal = {Sevaka : Hasil Kegiatan Layanan Masyarakat},
year = {2024},
doi = {10.62027/sevaka.v2i1.47}
}
EUVIMED